Microvision Inc

This proposal asks shareholders to approve, under Nasdaq Listing Rule 5635(d), the potential issuance of common stock (or securities convertible into common stock) in excess of 20% of the outstanding shares in connection with the 2026 Convertible Notes issued on February 23, 2026. Management seeks approval because the convertible notes contain conversion features and redemption mechanisms that could otherwise be restricted by Nasdaq rules absent shareholder approval, and failure to obtain approval would limit the Holder’s ability to convert or receive shares, forcing the company to make potentially substantial cash payments. The financing provided by the 2026 Convertible Notes (aggregate principal $43 million, zero coupon, secured, maturing March 1, 2028) is presented as an important component of MicroVision’s broader financing plan to support commercial scaling, inventory and integration of acquired assets, and working capital needs. The Board emphasizes the flexibility to settle certain redemption obligations in shares rather than cash as a key rationale for approval, which would preserve cash for operations and commercialization. The proposal includes a specific numeric cap (61,315,971 shares) representing the 20% threshold that shareholders are being asked to approve exceeding. If shareholders do not approve, conversion limits remain in place, which could materially increase the company’s near-term cash obligations and potentially deter future financing if prospective investors perceive shareholder resistance. The Board recommends a FOR vote and frames the request as essential to executing the company’s strategic plan while balancing near-term shareholder interests and long-term company viability. From a governance perspective, the approval would remove a conversion constraint tied to Nasdaq compliance and provide the Board and management greater financing flexibility, but it also raises potential dilution concerns that shareholders should weigh against the cash-preservation benefits described by management.

This management proposal asks shareholders to authorize an amendment to the Certificate of Incorporation so the Board may effect, within one year of shareholder approval, a reverse stock split at a whole-number ratio between 1-for-5 and 1-for-15, with the Board to select the exact ratio and timing. Management seeks this authority primarily to regain compliance with Nasdaq’s $1.00 minimum bid price requirement after receiving a notice of noncompliance and to improve the stock’s market perception to attract institutional and other investors constrained by low-price policies. The company frames the reverse split as a tool to preserve Nasdaq listing status, enhance capital-raising flexibility, and increase appeal to long-term investors, while noting risks including possible post-split price decline, reduced liquidity, and increased proportion of authorized-but-unissued shares that could be used in future issuances. The amendment would not reduce the number of authorized shares, so the reverse split would increase the number of authorized but unissued shares available for future issuance, which has potential anti-takeover implications and dilution risk. The Board emphasizes the discretionary nature of the proposal, including its right to abandon the reverse split before effectiveness, and recommends a FOR vote as a measured step to address regulatory listing risk and support strategic financing options. Shareholders should weigh the immediate regulatory benefits and potential to attract institutional capital against the dilution and liquidity trade-offs, as well as the possibility that additional corporate actions (including future reverse splits) may be required if market performance does not improve.

This non-binding advisory proposal asks shareholders to approve the company's named executive officer compensation as disclosed, reflecting a pay-for-performance philosophy emphasizing at-risk compensation tied to financial and strategic goals. Management seeks the advisory vote to obtain shareholder feedback and to comply with Section 14A, with the Compensation Committee and Board committing to consider the outcome when setting future pay. The disclosure highlights performance metrics such as revenue and cash operating expenses and describes incentive structures including RSU-based short-term bonuses and long-term equity incentives to align management decisions with shareholder value. Although advisory and not binding, a strong negative vote could prompt the Compensation Committee to reevaluate incentive targets, mix between cash and equity, or governance practices; conversely, shareholder approval provides affirmation for current compensation strategy. The Board recommends a FOR vote, arguing the program attracts and retains key talent during a period of strategic execution while aligning pay with company objectives. Investors should weigh the structure and realized pay versus disclosed targets, consistency with performance outcomes and the company’s capitalization and dilution implications from equity awards when evaluating the proposal.